Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy & Immunology
Study shows using controller therapy means fewer ER visits by asthmatic children
June 30th, 2005
Young children who are adherent with asthma controller therapies overall, specifically Pulmicort Respules (budesonide inhalation suspension), have lower exacerbation rates, while those less adherent did not experience the same benefits, according to data presented at the 100th American Thoracic Society International Conference. This study examined the relationship between patient outcomes and medication adherence with controller therapies, such as Pulmicort Respules, a nebulized inhaled corticosteroid used in the management of asthma. Patients who were more adherent (as defined by 2 or more prescriptions in the 1 year period) to controller therapy...
Source: Women's Health Weekly (2005-06-30)
|
